Shares of Waters Corporation (NYSE:WAT - Get Free Report) passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $445.18 and traded as low as $437.54. Waters shares last traded at $439.73, with a volume of 1,353,532 shares traded.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the company. Evercore boosted their price target on Waters from $410.00 to $480.00 in a research note on Wednesday, October 7th. Piper Sandler raised shares of Waters from a "neutral" rating to an "overweight" rating and increased their target price for the stock from $400.00 to $480.00 in a report on Thursday, August 27th. Citigroup increased their price objective on shares of Waters from $470.00 to $536.00 and gave the stock a "buy" rating in a research note on Wednesday, November 4th. Leerink Partners upped their target price on shares of Waters from $420.00 to $450.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Finally, Weiss Ratings raised Waters from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, October 8th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $475.48.
View Our Latest Report on Waters
Waters Stock Down 3.7%
The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.28 and a current ratio of 1.89. The company has a market cap of $43.22 billion, a P/E ratio of 188.73, a price-to-earnings-growth ratio of 2.58 and a beta of 1.16. The business's fifty day moving average is $445.18 and its two-hundred day moving average is $376.00.
Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.00 by $0.10. The firm had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.75 billion. Waters had a return on equity of 9.91% and a net margin of 1.75%. The business's revenue for the quarter was up 120.9% on a year-over-year basis. During the same quarter last year, the firm posted $3.40 earnings per share. Equities analysts predict that Waters Corporation will post 14.65 EPS for the current year.
Hedge Funds Weigh In On Waters
Several institutional investors and hedge funds have recently modified their holdings of WAT. Resources Management Corp CT ADV acquired a new stake in shares of Waters in the 1st quarter worth $27,000. Westside Investment Management Inc. acquired a new stake in Waters in the third quarter valued at $27,000. PenderFund Capital Management Ltd. acquired a new position in Waters in the second quarter valued at $28,000. Meeder Asset Management Inc. grew its position in Waters by 200.0% during the 3rd quarter. Meeder Asset Management Inc. now owns 63 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 42 shares during the last quarter. Finally, Bollard Group LLC acquired a new position in Waters in the 1st quarter valued at $29,000. Institutional investors and hedge funds own 94.01% of the company's stock.
About Waters
(
Get Free Report)
Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.